Search results
Heart disease: Moderate intake of choline may help reduce risk
Medical News Today· 1 day agoCholine is a nutrient essential for heart health and brain function and is found in many foods like...
Statins for heart disease prevention could be recommended for far fewer Americans if new risk...
Medical Xpress· 3 days agoIf national guidelines are revised to incorporate a new risk equation, about 40% fewer people could...
New Analysis Finds Millions of People on Statins May Not Need Them
Healthline via AOL· 1 day agoThis includes equations like PCE and PREVENT. New analysis may be more accurate at predicting heart ...
Ventyx Biosciences stock holds at Neutral amid competitor's trial results By Investing.com
Investing.com· 8 hours agoOn Thursday, H.C. Wainwright maintained a Neutral stance on Ventyx Biosciences Inc (NASDAQ:VTYX),...
Man died at Tacoma immigration detention center of natural causes, medical examiner says
Tacoma News Tribune via Yahoo News· 2 days agoCharles Leo Daniel, a citizen of Trinidad and Tobago, died March 7 of hypertensive and ...
Carl Weathers Honored by Directors Guild Foundation in Renaming of Golf Tournament
The Wrap via Yahoo News· 1 day ago"We celebrate the invaluable contributions of this remarkable man that has enriched our community,"...
Can statins help prevent cancer? New study offers clues
MedicalNewsToday via AOL· 5 days agoA recent study found that using the statin pitavastatin may assist in blocking a particular...
Jun 07 2024 This Week in Cardiology
Medscape· 7 days agoFor more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast, download the Medscape app or subscribe on Apple...
Dynamic Troponin Changes Unreliable for MI in Acute Stroke
Medscape· 7 days agoIn acute ischemic stroke, high baseline, high-sensitivity cardiac troponin values are a better indicator of myocardial infarction than dynamic changes in troponin levels, new data suggested.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives $9.33 Consensus Target Price from Analysts
ETF DAILY NEWS· 2 days agoEsperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) has earned an average rating of “Hold” from the five analysts that are currently covering the company, MarketBeat reports. Three research ...